Erectile Dysfunction in Patients Treated with Selpercatinib for <i>RET</i>-Altered Thyroid Cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Antonio,Matrone

第一单位： Department of Clinical and Experimental Medicine, Unit of Endocrinology, Pisa University Hospital, Pisa, Italy.

作者： Antonio,Matrone ^[1] ; Matthias,Kroiss ^[2] ; Matti L,Gild ^[3] ; Sarah,Hamidi ^[4] ; Cyrus Michael,Sayehli ^[5] ; Rhonda,Siddal ^[6] ; Carla,Gambale ^[1] ; Alessandro,Prete ^[1] ; Mimi I,Hu ^[4] ; Bruce G,Robinson ^[3] ; Rossella,Elisei ^[1]

作者单位： Department of Clinical and Experimental Medicine, Unit of Endocrinology, Pisa University Hospital, Pisa, Italy. ^[1] Department of Internal Medicine IV, Chair of Endocrinology/Diabetology, LMU University Hospital, LMU Munich, Munchen, Germany.;Department of Internal Medicine I, Chair of Endocrinology/Diabetology, University Hospital Würzburg, University of Würzburg, Munchen, Germany. ^[2] Department of Endocrinology and Diabetes, Royal North Shore Hospital, Sydney, Australia.;Faculty of Medicine and Health, University of Sydney, Sydney, Australia. ^[3] Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer, Houston, Texas, USA. ^[4] Interdisciplinary Trial Center with Early Clinical Trial Unit, University Hospital Würzburg, Wurzburg, Germany. ^[5] Department of Endocrinology and Diabetes, Royal North Shore Hospital, Sydney, Australia. ^[6]